HealthEquity Inc (HQY)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $8.56B
Last updated: Nov 17, 2026 at 11:06 AM ET
HealthEquity Inc (HQY) P/E Ratio & Valuation History
HealthEquity (HQY) trades at 25.7x trailing earnings and 6.4x sales. Its P/E of 25.7x is below its 5-year median of 33.3x. Its forward P/E is 19.1x. The median P/E across 6 similar companies is 38.4x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 34.6% higher over the next year. Its free cash flow yield is 5.0%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 25.7x |
| Forward P/E | 19.1x |
| Price to sales | 6.4x |
| Price to book | 4.4x |
| EV/EBITDA | 18.1x |
| Price to FCF | 20.0x |
| EV/FCF | 21.6x |
| PEG | 1.3 |
| FCF yield | 5.0% |
Historical Medians
Against its 10-year medians, its P/E is 36.5% below 40.5x, its P/S is 8.6% below 7.0x and its P/B is 18.9% above 3.7x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 25.7x | 33.3x | 40.5x |
| P/S | 6.4x | 6.3x | 7.0x |
| P/B | 4.4x | 3.3x | 3.7x |
Valuation History
Over the 10 year ends shown, its P/E ranged from 24.4x in 2025 to 81.0x in 2016. 2025 was the lowest of those years.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $91.61 | 24.4x | 6.2x | 3.7x |
| 2024 | $95.95 | 31.3x | 7.3x | 3.9x |
| 2023 | $66.30 | 33.1x | 5.8x | 2.9x |
| 2022 | $61.64 | 52.2x | 6.2x | 2.8x |
| 2021 | $44.24 | 28.5x | 4.9x | 2.0x |
| 2020 | $69.71 | 42.2x | 6.8x | 3.9x |
| 2019 | $74.07 | 46.3x | 12.0x | 5.1x |
| 2018 | $59.65 | 57.4x | 13.6x | 8.1x |
| 2017 | $46.66 | 70.7x | 13.0x | 8.5x |
| 2016 | $40.52 | 81.0x | 14.2x | 9.5x |
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About HQY
What is HQY's forward P/E ratio?
HealthEquity has a forward P/E ratio of 19.1x.
Is HQY stock overvalued?
GNG's valuation label for HQY is Fairly valued. Its P/E of 25.7x compares with a median of 38.4x across 6 similar companies.
What is HQY's price to sales ratio?
HealthEquity has a price to sales ratio of 6.4x.
What is HealthEquity's average P/E ratio over 5 years?
HealthEquity's median P/E over the last 5 years is 33.3x, from 60 month-end values through Oct 2026.
What is HQY's PEG ratio?
HealthEquity has a PEG ratio of 1.3.
HQY pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts